NBIX
$NBIX
Neurocrine Biosciences, Inc.
Neuroscience-focused biotech developing treatments for neurological and endocrine disorders.
Healthcare$129.70
-1.01 (-0.77%)
Day Range$127.07 - $132.25
Prev Close$130.71
Analyst Rating
Strong Buy
31 Buy / 5 Hold / 0 Sell
Subscribers
0
Tracking this ticker
Next Report
Sun, Mar 22
Weekly updates
Latest Report
NBIX: Growth and Valuation, with Upcoming Catalysts
Neurocrine Biosciences ($NBIX) combines steady revenue growth, healthy margins and a low-debt balance sheet with a bullish analyst consensus. Upcoming investor events and a modest pullback create actionable catalyst windows to monitor.
Mar 16, 2026